|
UBQLN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.74869999997252E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.54069999483519E-08 |
| Normal-vs-Stage2 |
2.972200E-01 |
| Normal-vs-Stage3 |
9.146600E-01 |
| Normal-vs-Stage4 |
8.152300E-02 |
| Stage1-vs-Stage2 |
6.908300E-02 |
| Stage1-vs-Stage3 |
9.422300E-03 |
| Stage1-vs-Stage4 |
6.772600E-01 |
| Stage2-vs-Stage3 |
3.894400E-01 |
| Stage2-vs-Stage4 |
4.973400E-01 |
| Stage3-vs-Stage4 |
1.828020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.08129999995843E-06 |
| Normal-vs-AfricanAmerican |
9.584600E-04 |
| Normal-vs-Asian |
9.995800E-03 |
| Caucasian-vs-AfricanAmerican |
9.801600E-01 |
| Caucasian-vs-Asian |
8.331600E-01 |
| AfricanAmerican-vs-Asian |
8.271800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.21069995432322E-09 |
| Normal-vs-Female |
9.066000E-01 |
| Male-vs-Female |
2.41489999999178E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.122320E-03 |
| Normal-vs-Extreme_Weight |
3.3041000002676E-07 |
| Normal-vs-Obese |
3.729700E-02 |
| Normal-vs-Extreme_Obese |
9.62409999999414E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.519000E-01 |
| Normal_Weight-vs-Obese |
2.388800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.935600E-01 |
| Extreme_Weight-vs-Obese |
3.635900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.120800E-01 |
| Obese-vs-Extreme_Obese |
7.028200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.925000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.520470E-03 |
| Normal-vs-Age(61-80Yrs) |
4.324000002498E-08 |
| Normal-vs-Age(81-100Yrs) |
1.101560E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.798580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.381100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.657900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.215920E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.112800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.083200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.47680004178608E-09 |
| Normal-VS-Type2 PRCC |
7.957900E-03 |
| Normal-VS-KIRP CIMP |
2.208800E-01 |
| Normal-VS-Unclassified PRCC |
1.349830E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.039700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.647780E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.843700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.244200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.094600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.505700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.230400E-04 |
| Normal-vs-N1 |
5.743800E-01 |
| Normal-vs-N2 |
5.821200E-01 |
| N0-vs-N1 |
2.249500E-02 |
| N0-vs-N2 |
1.454160E-01 |
| N1-vs-N2 |
9.859800E-01 |
|
|
